Construction is expected to start in the fourth quarter of this year, with completion anticipated by the end of 2027. Cleveland Clinic London says the centre will offer one of the most comprehensive cancer programmes in the UK independent market. Multidisciplinary cancer care will include surgical oncology, medical oncology, and haematology – including systemic cancer therapies, such as immunotherapy, chemotherapy, targeted therapies, and radiotherapy tailored to each patient. Alongside cancer care, Cleveland Clinic London plans to introduce a wider range of clinical services at the facility in the future.
According to Cancer Research UK, over 375,000 new cancer cases are diagnosed annually in the UK, and the rate is expected to rise as the population ages. The most common types of cancer diagnosed are breast, lung, prostate, and colorectal cancer.
“We are proud to expand our services in London, and are committed to the needs of our community,” said Rob Lorenz, M.D., Cleveland Clinic London President. “Signing the lease on what will become our new cancer centre is a major milestone in providing our patients with access to best-in-class expertise, research, and technology, to strengthen cancer care in the UK.”
Across its international locations, Cleveland Clinic says it delivers ‘comprehensive cancer care and the latest treatments, enhanced by innovative basic, clinical, and translational research’. The health system’s global cancer team includes more than 800 physicians, researchers, nurses, and technicians, who care for thousands of patients annually, and provide access to a wide range of clinical trials. Consultants at Cleveland Clinic London will collaborate closely with colleagues at Cleveland Clinic’s ‘renowned cancer programme’ in the US and Abu Dhabi to bring multidisciplinary care, precision medicine, research, and ‘the most advanced cancer therapies’, to patients in the UK.